Hennion & Walsh Asset Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.54M Buy
519,120
+127,644
+33% +$755K 0.1% 253
2026
Q1
$1.75M Buy
391,476
+83,019
+27% +$386K 0.06% 381
2025
Q4
$1.7M Buy
+308,457
New +$1.5M 0.06% 394

Other funds holding TSHA